Jazz Pharmaceuticals Director & Officer Renee Gala Files Form 144 to Sell $225K in Stock

Executive Summary

On November 3, 2026, Renee D. Gala, an Officer and Director of Jazz Pharmaceuticals plc ($JAZZ), filed a Form 144 notice disclosing the proposed sale of 1,000 shares of common stock with an aggregate market value of approximately $225,370. The sale is being executed through Morgan Stanley Smith Barney LLC.

Transaction Details

• Security: Common Stock
• Shares Proposed for Sale: 1,000
• Aggregate Market Value: $225,370.00 (~$225.37 per share)
• Shares Outstanding: 64,189,052
• Relative Size: Approximately 0.0016% of total shares outstanding
• Acquisition Origin: 1,000 shares acquired as restricted stock directly from the issuer on June 30, 2026.

Rule 10b5-1 Plan & Recent Selling History

• 10b5-1 Plan Adoption: The transaction is governed by a pre-established trading plan adopted on June 4, 2026.
• Past 3 Months Activity:
  • October 6, 2026: Sold 2,000 shares for gross proceeds of $472,800.00.
  • September 8, 2026: Sold 2,000 shares for gross proceeds of $486,060.00.

Market & Trading Significance

The trading significance is evaluated as Low. The proposed disposition represents a negligible portion of the company's outstanding equity float and is executed pursuant to a pre-scheduled Rule 10b5-1 trading plan following regular vesting of restricted stock awards.